Capital Advisors, Ltd. LLC Neurocrine Biosciences Inc Transaction History
Capital Advisors, Ltd. LLC
- $759 Million
- Q1 2025
A detailed history of Capital Advisors, Ltd. LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 23 shares of NBIX stock, worth $2,476. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 53
56.6%
Holding current value
$2,476
Previous $7,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
95.4MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.53 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$527 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$325 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$273 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...